305 related articles for article (PubMed ID: 17269993)
1. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
[TBL] [Abstract][Full Text] [Related]
2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials.
Qadeer MA; Phillips CO; Lopez AR; Steward DL; Noordzij JP; Wo JM; Suurna M; Havas T; Howden CW; Vaezi MF
Am J Gastroenterol; 2006 Nov; 101(11):2646-54. PubMed ID: 17037995
[TBL] [Abstract][Full Text] [Related]
5. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
Vakil N
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Qua CS; Wong CH; Gopala K; Goh KL
Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
[TBL] [Abstract][Full Text] [Related]
7. Review article: alternative approaches to the long-term management of GERD.
Fennerty MB
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
[TBL] [Abstract][Full Text] [Related]
9. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
[TBL] [Abstract][Full Text] [Related]
10. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
Bretagne JF; Honnorat C; Richard-Molard B; Caekaert A; Barthélemy P
Aliment Pharmacol Ther; 2006 Mar; 23(5):607-16. PubMed ID: 16480400
[TBL] [Abstract][Full Text] [Related]
12. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
Monini S; Di Stadio A; Vestri A; Barbara M
Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
Cremonini F; Wise J; Moayyedi P; Talley NJ
Am J Gastroenterol; 2005 Jun; 100(6):1226-32. PubMed ID: 15929749
[TBL] [Abstract][Full Text] [Related]
14. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and management problems of laryngopharyngeal reflux disease in children.
Stavroulaki P
Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):579-90. PubMed ID: 16359734
[TBL] [Abstract][Full Text] [Related]
16. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
17. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
[TBL] [Abstract][Full Text] [Related]
18. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
20. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
